CAS No.: 2070009-64-0
GSK2110183 analog 1 HCl Catalog No. CSN19148
Synonyms: Afuresertib-F;GSK-2110183-analog;Afuresertib-F HCl
GSK2110183 HCl is an orally bioavailable, selective, ATP-competitive and potent pan-Akt inhibitor with IC50s of 0.08/2/2.6 nM for Akt1/Akt2/Akt3 respectively.
| 规格 | 价格 | 促销价格 | 库存 | 数量 |
|---|
400-920-2911
sales@csnpharm.cn
tech@csnpharm.cn
纯度 & 质量文件
批次:
靶点选择性
生物活性
- 描述
- 临床研究
NCT号 适应症或疾病 临床期 招募状态 预计完成时间 地点 NCT01445587 Cancer Phase 2 Withdrawn(Based on the clinica... more >>l activity, not safety data, of the AKT inhibitor, GSK has decided at this time to suspend further development of GSK2110183 as monotherapy.) Collapse << November 2011 Australia, Victoria ... more >> GSK Investigational Site Melbourne, Victoria, Australia, 3004 Collapse <<
实验方案
- 计算器
- 储存液制备
技术信息
| CAS号 | 2070009-64-0 | 储存条件 |
|
|
| 分子式 | C18H17Cl3F2N4OS | 运输 | 蓝冰 | |
| 分子量 | 481.77 | 别名 | Afuresertib-F;GSK-2110183-analog;Afuresertib-F HCl;Afuresertib-F hydrochloride |
